NCT06674538View on ClinicalTrials.gov

Clinical Trial to Treat Stage IV Cancer Patients

PHASE1Enrolling by invitationINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

December 30, 2024

Primary Completion Date

January 31, 2027

Study Completion Date

January 31, 2029

Conditions
Soft Tissue Cancer
Interventions
DRUG

Moonshot antibodies

Chimeric antibodies

Trial Locations (1)

17033

Penn State Cancer Institute, Hershey

Sponsors
All Listed Sponsors
lead

Moonshot Antibodies

INDUSTRY

NCT06674538 - Clinical Trial to Treat Stage IV Cancer Patients | Biotech Hunter | Biotech Hunter